These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10321260)

  • 1. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation].
    Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):514-7. PubMed ID: 10321260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation].
    Muizelaar JP
    Ned Tijdschr Geneeskd; 1999 May; 143(20):1063. PubMed ID: 10368734
    [No Abstract]   [Full Text] [Related]  

  • 3. Study control, violators, inclusion criteria and defining explanatory and pragmatic trials.
    McMahon AD
    Stat Med; 2002 May; 21(10):1365-76. PubMed ID: 12185890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality of reporting and outcome measures in randomized clinical trials related to upper-extremity disorders.
    Gummesson C; Atroshi I; Ekdahl C
    J Hand Surg Am; 2004 Jul; 29(4):727-34; discussion 735-7. PubMed ID: 15249101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methodological quality assessment of clinical trials in traditional Chinese medicine: the principles of evidence-based medicine].
    Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):1-6. PubMed ID: 16409958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
    Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
    BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: II. Participant samples and assessment.
    Del Boca FK; Darkes J
    Addiction; 2007 Aug; 102(8):1194-203. PubMed ID: 17511752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pragmatic clinical trials.
    Macpherson H
    Complement Ther Med; 2004; 12(2-3):136-40. PubMed ID: 15561524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epilogue. The imperative for truly scientific outcome analyses.
    Bourne RB
    Can J Surg; 1995 Feb; 38 Suppl 1():S67-8. PubMed ID: 7874634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trials: the meeting place of medical practice and clinical research.
    Hughes EG
    Semin Reprod Med; 2003 Feb; 21(1):55-64. PubMed ID: 12806560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome measures in multiple sclerosis clinical trials.
    Andersson PB; Goodkin DE
    Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical aspects of conducting a pragmatic randomised trial in primary care: patient recruitment and outcome assessment.
    van der Windt DA; Koes BW; van Aarst M; Heemskerk MA; Bouter LM
    Br J Gen Pract; 2000 May; 50(454):371-4. PubMed ID: 10897533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Explanatory clinical trials and pragmatic clinical trials on clinical effective evaluation of acupuncture].
    Wang YJ; Guo YM; Guo Y
    Zhongguo Zhen Jiu; 2010 Jun; 30(6):509-12. PubMed ID: 20578393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roaming through methodology. XXV. Outcome measures, surrogate outcomes, and intermediate measures].
    Boers M
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1949-52. PubMed ID: 11048558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change-to-Open-Label Design. Proposal and discussion of a new design for clinical parallel-group double-masked trials.
    Högel J; Walach H; Gaus W
    Arzneimittelforschung; 1994 Jan; 44(1):97-9. PubMed ID: 8135885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding clinical trial outcomes: design, analysis, and interpretation.
    Jacobe HT; Leitenberger JJ; Bergstresser PR
    Dermatol Ther; 2007; 20(2):77-85. PubMed ID: 17537135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.